Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
866
Sort by:
Global Rabies Vaccine Industry Market Research Report
US$ 2,960.00
... characteristics of the Rabies Vaccine market. The Rabies Vaccine market can be split based on product types, major applications, and important regions. Major Players in Rabies Vaccine market are: Chengda Sanofi ... -exposure Prophylaxis Most widely used downstream fields of Rabies Vaccine market covered in this report are: Vero Cell Rabies Vaccine BHK Chick Embryo Cell Rabies Vaccine Other
June 2017
155 pages
North America Pneumococcal Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... North America Pneumococcal Vaccine market. Chapter 1, to describe Pneumococcal Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Pneumococcal Vaccine ...
May 2017
115 pages
North America All Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... North America All Vaccine market. Chapter 1, to describe All Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of All Vaccine ...
May 2017
122 pages
United States All Vaccine Market by Manufacturers, States, Type and Application, Forecast to 2022
US$ 4,480.00
... Other Market Segment by Applications, can be divided into For Adult For Child There are 17 Chapters to deeply display the United States All Vaccine market. Chapter 1, to describe All Vaccine Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of All Vaccine ...
May 2017
122 pages
Global Anti-Infective Vaccines Market Analysis & Forecast Report 2017-2022
US$ 2,600.00
The Global Anti-Infective Vaccines Market Analysis & Forecast Report 2017-2022 is a professional and in-depth study on the current state of the Anti-Infective Vaccines Market. The report analysis the global market of Anti-Infective Vaccines by main manufactures and geographic regions. The report includes Anti-Infective Vaccines definitions, classifications, applications and ...
February 2017
103 pages
Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)
US$ 2,000.00
... on immunization programmes by various NGO’s. Global Anti- infective vaccine Market is forecasted to grow at a CAGR ... Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021)", Global Anti-Infective Vaccine market ...
February 2017
220 pages
Global Lung Cancer Vaccine Market & Pipeline Outlook 2022
US$ 2,000.00
... clinical and non-clinical trends in the global lung cancer vaccine market. Currently there are 3 lung cancer vaccines commercially available in the market. This report analyzes the ongoing clinical trial of 30 lung cancer vaccines in clinical pipeline and gives comprehensive clinical ...
December 2016
150 pages
United States Influenza Vaccine Market, Vaccination Analysis, Distribution, Production, Pipeline Insights, Clinical Trials, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022
US$ 1,000.00
... , the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed ...
December 2016
122 pages
Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022
US$ 2,000.00
... seasonal influenza vaccine markets in the US, the UK, France, Italy, Spain, Germany and Japan, comprising of market size, total number of persons vaccinated, number of children vaccinated, number of 60+ years of age persons vaccinated ...
November 2016
205 pages
Global HIV Vaccine Market & Clinical Trial Outlook 2022
US$ 2,000.00
... HIV) Vaccines HIV Vaccine Development Process Modified Approaches for HIV Vaccine Development HIV Drugs Taxonomy & Resistance Decisive Factors for Commercialization of HIV Vaccines Global HIV Vaccine Clinical Pipeline by Company, Indication & Phase Global HIV Vaccine Clinical Pipeline: 65 Vaccines ...
November 2016
200 pages
Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021
US$ 5,650.00
... following pointers: Market Penetration: Comprehensive information on the product portfolios of the top players in the vaccines market. The report analyses the vaccines market by technology, type, disease indication, end-users, and regions Product Development/Innovation: Detailed insights on the upcoming technologies ...
August 2016
159 pages
Global - Adult Vaccines Market, Company Analysis and Forecast to 2021
US$ 1,490.00
... position in the adult vaccines market landscape. GSK slipped to third position in the global adult vaccines market in 2014. While Pfizer stands at the fourth spot in the adult vaccines market landscape. Adult Vaccines Market - Disease Wise Company Sales Analysis GSK generates maximum adult vaccines sales ...
August 2016
239 pages
US Cancer Vaccine Market Outlook 2022
US$ 1,200.00
... US is largest market for cancer vaccines. The growth of the US cancer vaccine market is driven by increasing cancer incidence in the country, rising awareness, and strong pipeline. The “US Cancer Vaccine Market Outlook 2022” report provides detailed analysis of the market. This ...
July 2016
135 pages
Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021
US$ 5,650.00
... vaccine adjuvants market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various vaccine adjuvants across geographies Market Diversification: Exhaustive information about new products ...
June 2016
159 pages
Global Influenza Vaccine Market Outlook 2022
US$ 2,100.00
... fast growing market. The latest research by RNCOS titled, “Global Influenza Vaccine Market Outlook 2022” unfolds the market dynamics of the influenza vaccine market. The report shows the global influenza vaccine industry being segmented on the basis of major vaccine in the market. Followed ...
June 2016
95 pages
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics 2016
US$ 225.00
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics 2016 This Competitive Intelligence Report about prophylaxis and therapy of Clostridium difficile infections provides a competitor evaluation in the field of new molecules ... for prevention and treatment of Clostridium difficile infections. In addition, the report lists company-specific R&D pipelines of C. difficile vaccines and therapeutics. Competitor projects are listed in a tabular ...
June 2016
34 pages
Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis
US$ 1,390.00
... pediatric vaccines market, while, bioCSl captures least share of the global pediatric vaccines market. Pediatric Vaccines Market - Disease Wise Company Sales Analysis GSK and Sanofi Pasteur generates maximum pediatric vaccines revenue ... Pediatric Vaccines Market - Disease Wise Analysis to 2021 2. Global Pediatric Vaccines Market - Company Sales Analysis and Strategic Alliances 3. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast to 2021 4. Pediatric Vaccines Disease ...
May 2016
205 pages
Research Report on China Human Vaccine Industry, 2011-2020
US$ 2,400.00
... is human vaccine apart from animal vaccine. Five pharmaceutical giants, MSD, Sanofi, Glaxo SmithKline, Pfizer and Novartis ... vaccines in the Vaccine II catalogue include Pneumonia Vaccine, Varicella Vaccine, Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine and Rabies Vaccine. In China, Vaccine ...
April 2016
60 pages
Pediatric Vaccines - Global Market Outlook (2015-2022)
US$ 4,150.00
... development of vaccine is the major driver for the pediatric vaccine market. Increasing innovative technologies such as therapeutic and adjuvant vaccines are anticipated to fuel the pediatric vaccine market during the forecast period. Moreover, increasing expenditure of vaccines ...
March 2016
145 pages
Influenza Vaccines Market and Forecast - Global Analysis
US$ 1,400.00
... 4 viewpoints: 1. Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (2011 - 2021) 2. Global - Influenza Vaccines Brand Sales and Forecast to 2021 3. Global Influenza Vaccines Market - Major Deals 4. Global Influenza Vaccines Market - Driving Factors and Challenges Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution ...
February 2016
176 pages
Analyzing Edible Vaccines
US$ 750.00
... Research’s report on Analyzing Edible Vaccines is an in depth study on the basics of vaccines and the major types of vaccines which are present in ... edible vaccines such as the role of transgenic plants. A complete section of Aruvian’s report on analyzing edible vaccines is devoted to the process of vaccine ...
February 2016
85 pages
Competitor Analysis: Dengue Virus Vaccines, Antibodies & Antivirals
US$ 220.00
Competitor Analysis: Dengue Virus Vaccines, Antibodies & Antivirals This Competitive Intelligence Report provides a competitor evaluation in the field of approved and investigational vaccines and therapeutics against one or more ... Dengue virus for prophylaxis of Dengue fever and of therapeutics for treatment of Dengue fever. In addition, the report lists company-specific R&D pipelines of Dengue Virus Vaccines, Antibodies and Antivirals. Competitor ...
February 2016
42 pages
Competitor Analysis: Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines
US$ 330.00
Competitor Analysis: Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines The Competitive Intelligence Report Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines“ provides a competitor ...
February 2016
39 pages
Prophylactic Human Vaccines: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for Prophylactic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines. The report provides separate ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
January 2016
358 pages
Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines
US$ 345.00
Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines The Competitive Intelligence Report Amyloid beta- and Tau-Targeted Antibodies & Vaccines as of September 2015 provides a competitor analysis in the ... , the report lists company-specific R&D pipelines of amyloid beta- and tau-targeted antibodies & vaccines. Competitor projects are listed in a tabular format providing Information ...
September 2015
44 pages
Global Cancer Vaccine Market & Clinical Trial Insight
US$ 4,000.00
... cancer vaccines will hit the shelf in coming years. “Global Cancer Vaccine Market & Clinical Trial Insight” Report Highlights: Global Cancer Market Overview Emergence of Personalized Cancer Vaccines Platforms for Cancer Vaccines Delivery Mechanism of Cancer Vaccines Global Cancer Vaccines Clinical ...
September 2015
750 pages
Research Report on China Foot-and-Mouth Disease (FMD) Vaccine Industry, 2010-2019
US$ 2,000.00
... China policy environment and government purchase of FMD vaccine in China supply of and demand for FMD vaccine in China major producers of FMD vaccine and their operation status in China factors affecting development of FMD vaccine in China expectation to FMD vaccine industry in China ...
August 2015
40 pages
Global Pneumonia Vaccine Market Outlook 2020
US$ 1,500.00
... vaccines, there has been more disease reduction in both vaccinated and unvaccinated populations. As vaccines evolve, similar improvements can be expected. According to our report, “Global Pneumonia Vaccine Market Outlook 2020”, the Pneumonia vaccine market for 2014, which ...
June 2015
50 pages
US Cancer Vaccine Market Outlook 2020
US$ 2,000.00
... Cancer Vaccine Clinical Pipeline by Company, Indication & Phase US Cancer Vaccine Clinical Pipeline: 187 Vaccines Clinical Insight of Marketed Cancer Vaccines in US Marketed Cancer Vaccine in US: 5 Vaccines FDA Regulations for Clinical Trials of Cancer Vaccines Clinical Insight of Marketed Cancer Vaccines ...
May 2015
420 pages
Global HIV Vaccine Market Future Outlook
US$ 2,000.00
... Introduction to HIV Vaccines Issues Related to the Development of HIV Vaccines Parameters for Successful Commercialization of HIV Vaccines Global HIV Vaccines Market Opportunity Analysis Global HIV Vaccine Clinical Pipeline by Company & Phase Global HIV Vaccine Clinical Pipeline: 100 Vaccines Majority Vaccine ...
May 2015
275 pages
China Human Vaccine Industry Report, 2015-2018
US$ 2,500.00
... registration for meningococcal polysaccharide vaccine (Group A/C/Y/W 135) and other vaccines in Nigeria, Chile, Peru, Thailand, and India. China Human Vaccine Industry Report, 2015-2018 highlights the following: Operating environment, overall situation, sales channel, etc. of China human vaccine industry; Supply & demand ...
March 2015
138 pages
Global Lung Cancer Vaccine Market & Pipeline Insight 2015
US$ 1,200.00
... Lung Cancer Vaccine Global Lung Cancer Vaccine Market Analysis Global Lung Cancer Vaccine Pipeline by Company & Phase Global Lung Cancer Vaccine Pipeline: 29 Vaccines Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C & Vaxira) Personalized Cancer ...
February 2015
120 pages
Global Skin Cancer Vaccine Market & Pipeline Insight 2015
US$ 1,500.00
... Skin Cancer Vaccine Global Skin Cancer Vaccine Market Analysis Global Skin Cancer Vaccine Pipeline by Company & Phase Global Skin Cancer Vaccine Pipeline: 47 Vaccines Majority Skin Cancer Vaccines in Phase-I: 12 Vaccines Marketed Skin Cancer Vaccines ...
February 2015
179 pages
H1N1 Vaccines: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the US, ... 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
January 2015
137 pages
